Главная
Study mode:
on
1
Introduction
2
Bacterial Priority Pathogen List
3
Research and Targeting
4
CDC vs WHO
5
WHO fungal pathogen priority list
6
Methodology
7
Innovation
8
Innovation vs Inhibitors
9
Size of antibacterial research programs
10
High failure rate of antibacterial compounds
11
Lack of interest and investment
12
Pipeline composition
13
INDEnabling Phase
14
Mechanism of Action
15
Narrow Spectrum
16
Preclinic Programs
17
Limitations
18
Future
Description:
Explore the global preclinical antibacterial pipeline in this 38-minute conversation with Valeria Gigante, Team Lead at the World Health Organization's AMR Division. Delve into the process of reviewing the antibacterial pipeline, recognize progress and gaps in antibiotic discovery, and identify opportunities to overcome hurdles in early-stage antibacterial research and development. Gain insights on bacterial priority pathogen lists, research targeting, innovation challenges, pipeline composition, and future prospects. Understand the importance of antibiotic discovery in combating antimicrobial resistance and the economic challenges faced by the field. Learn about the latest WHO report on preclinical and clinical antibacterial development, methodologies used, and the composition of current pipelines, including IND-enabling phases and mechanism of action considerations.

The Global Preclinical Antibacterial Pipeline - Editors in Conversation

American Society for Microbiology
Add to list
0:00 / 0:00